Figures
Abstract
Iron is an important trace element involved in several biological processes. The role of iron in porcine early embryonic development remains unknown. In the present study, we depleted iron (III, Fe3+) with deferoxamine (DFM), a specific Fe3+ chelator, in cultured porcine parthenotes and monitored embryonic development, apoptosis, mitochondrial membrane potential, and ATP production. Results showed biphasic function of Fe3+ in porcine embryo development. 0.5 μM DFM obviously increased blastocyst formation (57.49 ± 2.18% vs. control, 43.99 ± 1.72%, P < 0.05) via reduced (P < 0.05) production of reactive oxygen species (ROS), further increased mitochondrial membrane potential and ATP production in blastocysts (P < 0.05). 0.5 μM DFM decreased mRNA expression of Caspase 3 (Casp3) and increased Bcl-xL. However, results showed a significant reduction in blastocyst formation in the presence of 5.0 μM DFM compared with the control group (DFM, 21.62 ± 3.92% vs. control, 43.99 ± 1.73%, P < 0.05). Fe3+ depletion reduced the total (DFM, 21.10 ± 8.78 vs. control, 44.09 ± 13.65, P < 0.05) and increased apoptotic cell number (DFM, 11.10 ± 5.24 vs. control, 2.64 ± 1.43, P < 0.05) in the blastocyst. An obvious reduction in mitochondrial membrane potential and ATP level after 5.0 μM DFM treatment was observed. Co-localization between mitochondria and cytochrome c was reduced after high concentration of DFM treatment. In conclusion, Fe3+ is essential for porcine embryonic development via mitochondrial function maintenance, but redundant Fe3+ impairs the function of mitochondria.
Citation: Zhao M-H, Liang S, Kim S-H, Cui X-S, Kim N-H (2015) Fe(III) Is Essential for Porcine Embryonic Development via Mitochondrial Function Maintenance. PLoS ONE 10(7): e0130791. https://doi.org/10.1371/journal.pone.0130791
Editor: Qing-Yuan Sun, Institute of Zoology, Chinese Academy of Sciences, CHINA
Received: February 21, 2015; Accepted: May 25, 2015; Published: July 10, 2015
Copyright: © 2015 Zhao et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: This work was supported by grants from the Next-Generation BioGreen 21 Program (PJ011126), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Iron plays an important role in cellular function in all organs and systems, particularly in rapidly growing and differentiating cells. In mammalian cells, iron is required for a variety of biochemical processes. It is a essential cofactor for non-heme enzymes for DNA synthesis and a vital component of the heme in hemoglobin, myoglobin and cytochromes [1]. Iron deficiency is known to cause multiple problems, including ventricular dilation [2], mitochondrial DNA damage [3], and hypertension in rat offspring [4]. In addition, nutritional iron deficiency is thought to trigger multiple cardiovascular diseases, including cardiac hypertrophy and chronic heart failure [5, 6].
Animals absorb iron from their diets, which contain two different forms of iron: inorganic non-heme iron in vegetables and grains and heme iron in red meat. Dietary non-heme iron exists mainly as iron (III, Fe3+), which binds to transferrin (Tf). The majority of cells absorb iron by Tf-mediated uptake via the transferrin receptor (TfR)-1. Iron uptake is roughly proportional to the number of TfRs on the cell surface. In erythroid cells, the low pH generated through the activity of a proton pump in endosome decreased the affinity of Tf for iron, and resulted in the release of Fe3+ from Tf in the endosome [7, 8]. Furthermore, Fe3+ is reduced to Fe2+ by a ferrireductase in the endosomal membrane, the six transmembrane epithelial antigen of the prostate 3 [9, 10].
Mitochondria are major powerhouses in all eukaryotic cells, producing ATP through oxidative phosphorylation and the citric acid cycle. Mitochondrial function is tightly controlled by cytoplasmic iron levels. Iron deficiency results in mitochondrial swelling, cytochrome c release [2], and mitochondrial DNA damage in rats [3]. In addition to their well-established role in providing the cell with ATP, mitochondria are the source of iron-sulfur clusters [11, 12] and heme-prosthetic groups [13] that are utilized by proteins throughout the cell in various critical processes. The mitochondria also have decreased respiratory control and gluconeogenesis after iron deficiency [14]. Mitochondria from iron-deficient rats exhibit partial uncoupling of the oxidative phosphorylation process. Iron deficiency also inhibits aconitase activity by damaging the Fe-S cluster and decreasing ATP production [15].
In oocytes and embryos, free Fe3+ can be reduced by increasing the levels of apo-Tf during embryonic development [16]. However, the levels of iron in oocytes and embryos [17, 18], follicular and uterine fluid [19] indicate that an essential role of iron for development. Although the function of iron in somatic cells is well established, its function in embryos development remains unknown.
DFM is an efficient chelating agent available for the treatment of iron overload [20, 21]. Solution in a sterile aqueous containing antiseptics was reportedly stable up to one week [22]. The toxicity of DFM on embryos did not be reported. However, intraperitoneal injection of DFM at 176 mg/kg (~250mmol/kg) to pregnant mice per day did not give development toxicity [23].
It is difficult to obtain pig embryos of homogeneous quality due to the relatively high incidence of polyspermy during in vitro fertilization [24]. Therefore, diploidparthenotes have frequently been used to study early development in the pig. In the present study, we evaluated the function of Fe3+ in porcine parthenotes development. To this end, we reduced the Fe3+ content in the embryos by DFM. The effect of DFM treatment was assayed by determining the embryonic development, ROS content, mitochondrial membrane potential, apoptosis and cytochrome c localization. To the best of our knowledge, this is the first report to address the function of Fe3+ in porcine embryos.
Materials and Methods
Unless otherwise indicated, all chemicals were purchased from Sigma Chemical Company (Sigma—Aldrich, St. Louis, MO, USA).
In vitro maturation (IVM) of porcine oocytes
Ovaries from prepubertal gilts were obtained from a local slaughterhouse (Farm story dodarm B&F, Umsung, Chungbuk, Korea) and transported to the laboratory at 37°C within 3 h of slaughter. Cumulus oocyte complexes (COCs) were aspirated from follicles ranging in diameters between 3 and 8 mm by a syringe with 18-gauge needle. Only COCs surrounded by a minimum of three layers of cumulus cells were selected for further studies. After aspiration, COCs were washed three times in TL-HEPES supplemented with 0.1% polyvinyl alcohol (PVA) and 0.05 g/L gentamycin. COCs were then cultured in TCM-199 medium supplemented with 0.1 g/L sodium pyruvate, 0.6 mM L-cysteine, 10 ng/mL epidermal growth factor, 10% porcine follicular fluid, 0.5 IU/mL luteinizing hormone, and 0.5 IU/mL follicle stimulating hormone for 44h. After IVM, oocytes were denuded by pipetting with 0.1% hyaluronidase. Denuded oocytes were collected for additional experiments.
Parthenogenetic activation and embryo culture
After maturation, denuded oocytes were parthenogenetically activated by two 1.1kV/cm DC pulses for 50 μs followed by 3h incubation in PZM-5 medium [25, 26] containing 7.5 μg/mL cytochalasin B. Embryos were cultured in IVC medium (PZM-5 supplemented with 0.4% bovine serum albumin BSA, w/v and 0.6mM L-cysteine) under light mineral oil for 7 days at 38.5°C in 5% CO2 (v/v). To evaluate the effect of DFM on embryonic development, various concentration levels of DFM were added to the medium.
Transferase-mediated dUTP nick-end labeling (TUNEL) assay
For evaluation of apoptosis in blastocyst, approximately 15 blastocysts from each group were washed three times in Dulbecco’s phosphate-buffered saline (dPBS) containing 0.1% PVA (dPBS/PVA) and then fixed in 3.7% paraformaldehyde (w/v) for 1 h at room temperature. After fixation, the blastocysts were permeabilized with 0.5% Triton X-100 (v/v) for 1 h at 38.5°C. Permeablized blastocysts were then incubated in fluorescein-conjugated deoxyuridine triphosphate (dUTP) and terminal deoxynucleotidyl transferase (Roche, Mannheim, Germany) in the dark for 1 h at 37°C. After nick labeling, the blastocysts were counterstained with 10 μg/mL Hoechst 33342 for 10 min at room temperature to label nuclei, followed by simple washing in dPBS/PVA, mounted under a coverslip, and examined under a fluorescence microscope (Nikon, Tokyo, Japan).
Mitochondrial membrane potential assay
To measure mitochondrial membrane potential (Δφm), blastocysts were washed three times with PBS and incubated in culture medium containing 0.5 μM 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethyl-imidacarbocyanine iodide (JC-1) (Invitrogen, Grand Island, NY, USA) at 37°C in 5% CO2 for 30 min. Membrane potential was calculated as the ratio of red florescence, which corresponded to activated mitochondria (J-aggregates), to green fluorescence, which corresponded to less-activated mitochondria (J-monomers) [27]. Fluorescence was visualized with a Zeiss inverted confocal microscope equipped with a 40× oil immersion objective (Zeiss, Jena, Germany). Images were processed with ZEN software (Zen Software, Manchester, UK). The fluorescence intensity in the control group was arbitrarily set to 1, and the relative fluorescence intensity in the treatment groups was then measured. Three separate experiments were performed with 10–15 blastocysts in each.
ATP content assay
The ATP content of 20 blastocysts was measured using a commercial assay (Invitrogen). Briefly, samples were washed three times with dPBS then transferred individually into 1 mL tubes on ice. The medium was removed, and blastocysts were lysed by freezing and thawing. Approximately 100 μl of ice-cold somatic cell reagent (FL-SAR) was added to each tube, and samples were incubated in an ice-water bath for 5 min. Thereafter, 100 μl of ice-cold assay buffer (diluted 1:25 with ATP assay buffer, FL-AAB) was added, and the tubes were maintained at room temperature for 5 min under limited light conditions. The ATP concentration was measured using a luminometer (Berthold, Wildbad, Germany) with a sensitivity of 0.01 pM. The ATP concentration in the control group was arbitrarily set to 1. Three separate experiments were performed with three replicates in each.
Real-time reverse transcript-polymerase chain reaction (real time RT-PCR)
mRNA extraction and cDNA synthesis were performed as previously described [28]. Briefly, mRNA was extracted from 10 blastocysts using Dynabeads mRNA Direct Kit (Dynal Biotech ASA, Oslo, Norway) followed by routine cDNA synthesis by reverse transcription (RT) of RNA using an oligo(dT)12–18 primer and SuperScript Reverse Transcriptase (Invitrogen) following the manufacturer’s instructions.
Real-time RT-PCR was performed using the five primer pairs listed in Table 1. Real-time RT-PCR was performed in a Bio-Rad PCR machine (Bio-Rad, Hercules, CA, USA). Relative gene expression was analyzed using the 2-ΔΔCt method [29]. Gapdh mRNA was used as an internal control. Three independent experiments were performed with triplicate samples in each case.
Real-time RT-PCR with Taqman for miRNA (miR) analysis
TaqMan microRNA assays were used to quantitate the miRNAs in the present study according to the conditions described previously [30]. Briefly, each 15 μl RT reaction contained purified 5 μl of RNA, 3 μl stem-loop RT primer, 1× RT buffer, 0.25 mM of each dNTP, 3.33 U/mL MultiScribe reverse transcriptase, and 0.25 U/mL RNase inhibitor. The reactions were incubated for 30 min at 16°C, 30 min at 42°C, 5 min at 85°C and then held at 4°C in an Applied Biosystems 6 thermocycler. Real-time RT-PCR for each microRNA assay was carried out in a 20 μL reaction that included 4 μl RT product, 1× TaqMan Universal PCR Master Mix, and 1 μL of 20× real-time solution containing TaqMan probe and primers. The amplification parameters for real-time RT-PCR were followed as set out in the manufacturer’s protocol. The threshold cycle (Ct) is defined as the fractional cycle number at which the fluorescence exceeds the fixed threshold of 0.2. U6 snoRNA was used as an internal control. Each experiment was repeated at least three times with three blastocysts per repeat. All primers, including those used for specific miRNA and cDNA synthesis and PCR amplification, and the kit used for miRNA analyses were purchased from Applied Biosystems (Bedford, MA, USA).
ROS content assay
In the experiments, ROS content of the treated and untreated embryos was measured at the blastocyst stage. The ROS content was quantified using the dichlorodihydrofluorescein diacetate (DCHFDA, Molecular Probes, Invitrogen) method, as previously described [31]. Live imaging and quantitation were conducted on a fluorescence microscope (Nikon, Tokyo, Japan) by using photoshop (CS2, Adobe, USA).
Evaluation of co-localization of mitochondrial and cytochrome c
Blastocysts were stained for mitochondria according to the method descried in the previous study [32]. Briefly, blastocysts were incubated in IVC medium supplemented with 0.5 μmol/L MitoTracker Red CMXRos (Molecular Probes, Eugene, OR) for 30 min in incubator with 5% CO2 for 30 minutes at 38.5°C, followed by three washes with dPBS/PVA for 20 minutes. Then the blastocysts were fixed in 3.7% (w/v) paraformaldehyde in dPBS/PVA at room temperature. After 1h of permeabilization in PBS containing 0.1% Triton X-100 at 38.5°C, blastocysts were then blocked with 3% BSA in dPBS for 1h. They were then labeled with 100 μg/ml anti-cytochrome c antibody (Abcam) in blocking solution overnight in 4°C then labeled by rhodamine labeled second antibody. Nuclear was staining with 10 μg/ml Hoechst 33342 in PBS for 10 minutes, followed by washing three times in PBS, and then mounted on glass slides. Blastocyst were observed with a laser-scanning confocal microscope (Zeiss LSM 710 META, Germany). Co-localization of mitochondrial and cytochrome c were evaluated by Person’s Correlation coefficient.
Statistical analysis
All data were analyzed using SPSS software version 11.0 (SPSS Inc., Chicago, IL USA). JC-1, DCDHF signal intensity, and gene expression were analyzed by one-way ANOVA. The percentages of embryos that developed to a particular stage were determined by Chi-square tests. P < 0.05 was considered statistically significant.
Results
Effect of different DFM concentrations on porcine parthenotes development
To determine the effect of DFM on embryo development, after maturation, oocytes were artificially activated and cultured in the presence of 0, 0.1, 0.5, 1.0, 3.0, and 5.0 μM DFM for 7 days. The results were shown in Fig 1. No obvious difference in cleavage rate was observed. Interestingly, 0.5 μM of DFM (57.49 ± 2.18%, n = 130) significantly enhanced blastocyst formation after in vitro culture compared with the 0.1 μM (43.64 ± 5.19%, n = 131) group and control group (43.99 ± 1.72%, n = 167, P < 0.05). However, 3.0 μM (29.58 ± 1.97%, n = 132) and 5.0 μM (21.62 ± 3.91%, n = 106) of DFM sharply reduced blastocyst formation (P < 0.05).After 5.0 μM of DFM treatment, the diameter of blastocyst was decreased in the treatment group (304.78 ± 12.17 μm, n = 29, P < 0.05) compared to control (526.15 ± 23.67 μm, n = 26). However, there was no significant difference between 0.5 μM of DFM and control groups (Fig 1B and 1C).
(A), Cleavage and blastocyst formation of porcine parthenotes cultured in the presence of different concentration of DFM. (B), Morphology and diameter of blastocysts cultured in the absence or present of 0.5 and 5.0 μM DFM. (C), The diameters were measured by image pro-plus software. Values represent means ± SEM from at least three separate experiments. Scale bar = 500 μm, *P < 0.05.
Effect of Fe3+ depletion on total cell number and apoptosis in blastocysts
To evaluate blastocyst quality, the total cell number and incidence of apoptosis were counted. 0.5 μM of DFM did not affect the total cell number of blastocysts. However, 5.0 μM DFM treatment significantly decreased the total cell number in blastocysts (21.10 ± 8.78, n = 90 vs. control, 44.09 ± 13.65, n = 91, P < 0.05). TUNEL staining showed that the number of apoptotic cells was significantly lower in 0.5 μM but higher in the 5.0 μM of DFM group than in the control (P < 0.05, Fig 2).
(A), Total cell number was determined by Hoechst 33342 (blue) staining. Apoptosis was determined by TUNEL (green) staining. (B) and (C), The number of total and apoptotic cells in porcine blastocysts developed in vitro. Black bar, control group; white bar, DFM 0.5 μM; gray bar, DFM 5.0 μM. Values represent means ± SEM from at least five separate experiments. *P < 0.05.
Effect of Fe3+ depletion on expression of apoptosis-related genes
To clarify the molecular mechanism of apoptosis induction, mRNAs of apoptosis-related genes were evaluated by real-time RT-PCR. Results showed that low concentration (0.5 μM) of DFM significantly (P < 0.05) decreased the expression of apoptosis-related gene Casp3. Compared with the control group, the expression of the anti-apoptosis gene Bcl-xL was significantly increased in blastocysts. However, there were no significant differences in the expression of Bax and Bcl 2 (Fig 3).
mRNA was extracted from blastocysts cultured in the absence or presence of DFM. Expressions of anti-apoptotic and apoptosis-related genes were analyzed by real-time RT-PCR. Black bar, control group; white bar, DFM 0.5 μM; gray bar, DFM 5.0 μM. *P < 0.05. Values are the mean ± SEM of 3–4 independent experiments.
We compared the expression of apoptotic related genes in the blastocysts after high concentration of DFM (5.0 μM) treatment. Fe3+ depletion significantly increased the mRNA expression of apoptotic genes Bax and Casp3 (P < 0.05), while the expression of the anti-apoptotic genes Bcl2 and Bcl-xL were decreased (P < 0.05, Fig 3).
Fe3+ depletion decreased the expression of miR-21 after 5.0 μM of DFM treatment (P < 0.05), but there were no significant differences in miR-15a and miR-16 expression levels in the all groups (Fig 4).
Apoptosis-related miRNAs were analyzed by TaqMan real-time RT-PCR. Black bar, control group; white bar, DFM 0.5 μM; gray bar, DFM 5.0 μM. *P < 0.05. Values are the mean±SEM of 3–4 independent experiments.
Effect of Fe3+ depletion on mitochondrial membrane potential and ATP production
To explore the mechanism by which Fe3+ depletion affected development of porcine parthenotes, the mitochondrial membrane potential and ATP content in blastocysts were checked. The results were shown in Figs 5 and 6. After low concentration (0.5 μM) of DFM treatment, the mitochondrial membrane potential was significantly increased (P < 0.05) compared to the control group. Similarly, the ATP content in DFM treated blastocysts was higher (P < 0.05) than in the control group. However, high concentration (5.0 μM) of DFM treatment not only reduced mitochondrial membrane potential, but also decreased the ATP content in blastocysts (P < 0.05).
(A), Membrane potential was calculated as the ratio of red florescence, which corresponds to activated mitochondria (J-aggregates), to green fluorescence, which corresponds to less-activated mitochondria (J-monomers). (B), Fluoresces of each blastocyst were analyses by image pro plus software. The control was arbitrarily set at 1. Black bar, control group; white bar, DFM 0.5 μM; gray bar, DFM 5.0 μM. Values represent means ± SEM from at least three separate experiments. Scale bar = 500 μm. *P < 0.05.
The control was arbitrarily set at 1. Black bar, control group; white bar, DFM 0.5 μM; gray bar, DFM 5.0 μM. Values represent means ± SEM from at least three separate experiments. *P < 0.05.
Effect of DFM on ROS content in the porcine blastocysts
To assess why DFM enhanced mitochondrial membrane potential, ROS content in blastocyst was determined. The results showed that relatively lower ROS content was found in the blastocysts which developed in the presence of 0.5 and 5 μM DFM. Higher DCDHF signal was observed in the blastocysts cultured in the absence of DFM. Fluorescence intensity in the DFM group was significantly lower (P < 0.05) than that in the control. However, there was no obvious difference of ROS content between 0.5 and 5 μM DFM groups (Fig 7).
(A), ROS in blastocysts were stained by DCDHF (green). (B), Fluorescence intensity was analyzed by Photoshop. Data corresponding to the control was arbitrarily set at 1. Black bar, control group; white bar, DFM 0.5 μM treatment group; gray bar, DFM 5.0μM treatment group. Values represent mean ± SEM from at least three separate experiments. Scale bar = 500 μm *, P < 0.05.
Effect of DFM on cytochrome c release
To explore the apoptotic pathway, the co-localization of mitochondria and cytochrome c was determined in control and high DFM treated blasotysts. Pearson’s R was employed to evaluate co-localization. Pearson’s R in Fe3+-depleted blastocysts was significantly reduced, indicating a poor co-localization of mitochondrial and cytochrome c than that in the control group, which displayed stronger co-localization of cytochrome c and MitoTracker (Fig 8).
(A), Blastocysts were labeled with a cytochrome c-specific antibody (green) and MitoTracker (red). (B), Co-localization was analyzed using Image pro plus. (C), Pearson’s R was used to compare the co-localization of cytochrome c and mitochondria. Black bar, control group; white bar, DFM 5.0 μM. Scale bar = 200μm, *P < 0.05. Values are the mean ± SEM of 3–4 independent experiments.
Discussion
In the present study, we found that Fe3+ plays biphasic roles in porcine parthenotes development (Fig 9). Our results shown that redundant iron resulted in high concentration of ROS, depletion of that redundant iron significantly reduced ROS content, and further protected function of mitochondria (Fig 9A). However, over-depletion of Fe3+ impaired the function of mitochondria, thus resulted in apoptosis in the blastocysts (Fig 9B).
(A), Redundant Fe3+ caused higher concentration of ROS in cytoplasm, thus depletion of redundant Fe3+ reduced ROS in the porcine parthenotes. (B), Fe3+ is essential for ATP production.
Although reduced free cytoplasmic iron increased embryo formation [16] by preventing production of ROS through Fenton’s reaction [33], iron participates in several biological processes. To determine the function of iron, we depleted free Fe3+ with high concentration of DFM. After depletion, blastocyst development was reduced in a dose-dependent manner and diameters were decreased in iron-deficient blastocysts. Mammalian blastocyst formation is dependent on establishment of trophectoderm (TE) ion and fluid transport mechanisms [34]. The Na+/K+ ATPase is also a critical mediator of blastocyst formation as it establishes a transtrophectoderm ionic gradient that directs fluid movement across the TE epithelium [35, 36], which directly results in blastocyst cavity formation. Na+/K+ ATPase function is closely related to ATP, which is produced by mitochondria. Based on this information, we hypothesized that iron deficiency in embryos affects the function of mitochondria.
To confirm the mechanism of low blastocyst formation and increased apoptosis, t ATP contents of blastocysts were determined. ATP production is the most important function of mitochondria. In the present experiment, the results showed that iron deficiency reduced ATP level in blastocysts. This finding might explain the reduction in blastocyst formation and diameter. Reduced ATP content after iron depletion also reflects the dysfunction of mitochondria.
To clarify the reason for lower ATP production after iron deficiency, we investigated mitochondrial function by measuring the mitochondrial membrane potential, which is critical for the production of ATP. During oocyte maturation, there is a significant increase in mitochondrial membrane potential [37]. Our previous study showed that decreased blastocyst formation is always accompanied by decreased mitochondrial membrane potential [38, 39], which agrees with the results presented herein.
The mechanism by which iron depletion reduces membrane potential is still unknown. However, ATP production is dependent on electron transfer in the mitochondria, which involves the Fe2+ and Fe3+ transition. In the electron transport chain, many Fe-S proteins participate in electron transfer. Formation of mitochondrial membrane potential is mediated by the proton gradient established by four complexes located on the mitochondrial membrane, indicated that iron depletion probably impairs the function of the four complexes, further blocking electron transfer and resulting in decreased membrane potential and ATP content.
Iron deficiency leads to serious apoptosis in blastocysts, which can be explained by the dysfunction of mitochondria. Mitochondria play a key role in the apoptotic process [40, 41]. Mitochondrial control of apoptosis has been described at several levels, including ATP production [42], mitochondrial membrane potential, and mitochondrial membrane permeability for the release of apoptogenic factors from the intermembrane space into the cytosol [43]. In the present experiment, co-localization analysis of cytochrome c and mitochondria showed that Fe3+ depletion induced release of cytochrome c from mitochondria. In mammalian cells, cytochrome c initiates a major Caspase activation pathway. In this pathway, a variety of apoptotic stimuli cause cytochrome c release from the mitochondria, which in turn induces a series of biochemical reactions that result in Caspase activation and subsequent cell death [44]. The released cytochrome c may explain the increased expression of Bax It belongs to the prodeath Bcl2 family proteins, which form the last gateway for cytochrome c release [45]. Released cytochrome c activates Casp3 expression, which was increased in the present study.
Reduced mitochondrial metabolic capacity results in decreased the percentage of blastocyst formation following parthenogenetic activation in the present study. Although there are epigenetic differences between parthenote and IVF embryos, they share same basic metabolism mechanism.
In conclusion, the present study showed that iron is essential for embryonic development, which confirmed the function of mitochondria, however, redundant iron impaired function of mitochondria via induction of high concentration of ROS.
Supporting Information
S1 Data. Original data include cleavage rate, blastocyst rate, total cell number, apoptosis cell number, mitochondrial membrane potential, ATP content, cytochrome c localization and expressions for gene and microRNA.
https://doi.org/10.1371/journal.pone.0130791.s001
(XLSX)
Acknowledgments
Following are results of a study on the “Leaders INdustry-university Cooperation” Project, supported by the Ministry of Education, Republic of Korea.
Author Contributions
Conceived and designed the experiments: MHZ XSC. Performed the experiments: MHZ SL. Analyzed the data: SHK. Contributed reagents/materials/analysis tools: NHK. Wrote the paper: MHZ.
References
- 1. Duce JA, Bush AI. Biological metals and Alzheimer's disease: implications for therapeutics and diagnostics. Progress in neurobiology. 2010;92(1):1–18. pmid:20444428.
- 2. Dong F, Zhang X, Culver B, Chew HG Jr., Kelley RO, Ren J. Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration. Clin Sci (Lond). 2005;109(3):277–86. Epub 2005/05/10. pmid:15877545.
- 3. Walter PB, Knutson MD, Paler-Martinez A, Lee S, Xu Y, Viteri FE, et al. Iron deficiency and iron excess damage mitochondria and mitochondrial DNA in rats. Proceedings of the National Academy of Sciences of the United States of America. 2002;99(4):2264–9. Epub 2002/02/21. pmid:11854522; PubMed Central PMCID: PMC122353.
- 4. Andersen HS, Gambling L, Holtrop G, McArdle HJ. Maternal iron deficiency identifies critical windows for growth and cardiovascular development in the rat postimplantation embryo. The Journal of nutrition. 2006;136(5):1171–7. Epub 2006/04/15. pmid:16614400.
- 5. Sluhots'ka IB, Serediuk NM, Vakaliuk IP, Sierna AM. [Clinical and hemodynamic characteristics of heart dysfunction in patients with iron deficiency anemia]. Likars'ka sprava / Ministerstvo okhorony zdorov'ia Ukrainy. 2002;(2):141–2. Epub 2002/06/21. pmid:12073249.
- 6. Okonko DO, Anker SD. Anemia in chronic heart failure: pathogenetic mechanisms. Journal of cardiac failure. 2004;10(1 Suppl):S5–9. Epub 2004/03/10. pmid:15007793.
- 7. Ponka P. Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood. 1997;89(1):1–25. Epub 1997/01/01. pmid:8978272.
- 8. Dunn LL, Suryo Rahmanto Y, Richardson DR. Iron uptake and metabolism in the new millennium. Trends in cell biology. 2007;17(2):93–100. Epub 2006/12/30. pmid:17194590.
- 9. Ohgami RS, Campagna DR, Greer EL, Antiochos B, McDonald A, Chen J, et al. Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. Nature genetics. 2005;37(11):1264–9. Epub 2005/10/18. pmid:16227996; PubMed Central PMCID: PMC2156108.
- 10. Sendamarai AK, Ohgami RS, Fleming MD, Lawrence CM. Structure of the membrane proximal oxidoreductase domain of human Steap3, the dominant ferrireductase of the erythroid transferrin cycle. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(21):7410–5. Epub 2008/05/23. pmid:18495927; PubMed Central PMCID: PMC2396704.
- 11. Balk J, Lobreaux S. Biogenesis of iron-sulfur proteins in plants. Trends in plant science. 2005;10(7):324–31. Epub 2005/06/14. pmid:15951221.
- 12. Lill R, Muhlenhoff U. Iron-sulfur protein biogenesis in eukaryotes: components and mechanisms. Annual review of cell and developmental biology. 2006;22:457–86. Epub 2006/07/11. pmid:16824008.
- 13. Rosell FI, Mauk AG. Spectroscopic properties of a mitochondrial cytochrome C with a single thioether bond to the heme prosthetic group. Biochemistry. 2002;41(24):7811–8. Epub 2002/06/12. pmid:12056913.
- 14. Masini A, Salvioli G, Cremonesi P, Botti B, Gallesi D, Ceccarelli D. Dietary iron deficiency in the rat. I. Abnormalities in energy metabolism of the hepatic tissue. Biochimica et biophysica acta. 1994;1188(1–2):46–52. Epub 1994/11/01. pmid:7947904.
- 15. Tong WH, Rouault TA. Metabolic regulation of citrate and iron by aconitases: role of iron-sulfur cluster biogenesis. Biometals: an international journal on the role of metal ions in biology, biochemistry, and medicine. 2007;20(3–4):549–64. Epub 2007/01/06. pmid:17205209.
- 16. Jeong YW, Hossein MS, Bhandari DP, Kim YW, Kim JH, Park SW, et al. Effects of insulin-transferrin-selenium in defined and porcine follicular fluid supplemented IVM media on porcine IVF and SCNT embryo production. Animal reproduction science. 2008;106(1–2):13–24. Epub 2007/05/08. pmid:17482776.
- 17. Nomizu T, Falchuk KH, Vallee BL. Zinc, iron, and copper contents of Xenopus laevis oocytes and embryos. Molecular reproduction and development. 1993;36(4):419–23. Epub 1993/12/01. pmid:8305203.
- 18. Kim AM, Vogt S, O'Halloran TV, Woodruff TK. Zinc availability regulates exit from meiosis in maturing mammalian oocytes. Nature chemical biology. 2010;6(9):674–81. Epub 2010/08/10. pmid:20693991; PubMed Central PMCID: PMC2924620.
- 19. Reubinoff BE, Har-El R, Kitrossky N, Friedler S, Levi R, Lewin A, et al. Increased levels of redox-active iron in follicular fluid: a possible cause of free radical-mediated infertility in beta-thalassemia major. American journal of obstetrics and gynecology. 1996;174(3):914–8. Epub 1996/03/01. pmid:8633668.
- 20. Marciani MG, Cianciulli P, Stefani N, Stefanini F, Peroni L, Sabbadini M, et al. Toxic effects of high-dose deferoxamine treatment in patients with iron overload: an electrophysiological study of cerebral and visual function. Haematologica. 1991;76(2):131–4. Epub 1991/03/01. pmid:1937171.
- 21. Hwang YF, Brown EB. Evaluation of Deferoxamine in Iron Overload. Archives of internal medicine. 1964;114:741–53. Epub 1964/12/01. pmid:14211586.
- 22.
Martindale W. Martindale: The Extra Pharmacopoeia. 30th ed. London: The Pharmaceutical Press; 1993. 2363 p.
- 23. Bosque MA, Domingo JL, Corbella J. Assessment of the developmental toxicity of deferoxamine in mice. Archives of toxicology. 1995;69(7):467–71. Epub 1995/01/01. pmid:8526742.
- 24. Thuan NV, Harayama H, Miyake M. Characteristics of Preimplantational Development of Porcine Parthenogenetic Diploids Relative to the Existence of Amino Acids In Vitro. Biology of Reproduction. 2002;67:1688–98. pmid:12444042
- 25. Cao Z, Sui L, Li Y, Ji S, Zhang X, Zhang Y. Effects of chemically defined medium on early development of porcine embryos derived from parthenogenetic activation and cloning. Zygote. 2012;20(3):229–36. pmid:21473795.
- 26. Suzuki C, Iwamura S, Yoshioka K. Birth of piglets through the non-surgical transfer of blastocysts produced in vitro. The Journal of reproduction and development. 2004;50(4):487–91. pmid:15329482.
- 27. Ge H, Tollner TL, Hu Z, Dai M, Li X, Guan H, et al. The importance of mitochondrial metabolic activity and mitochondrial DNA replication during oocyte maturation in vitro on oocyte quality and subsequent embryo developmental competence. Molecular reproduction and development. 2012;79(6):392–401. Epub 2012/04/03. pmid:22467220.
- 28. Zhao MH, Kwon JW, Liang S, Kim SH, Li YH, Oh JS, et al. Zinc regulates meiotic resumption in porcine oocytes via a protein kinase C-related pathway. PloS one. 2014;9(7):e102097. Epub 2014/07/16. pmid:25019390; PubMed Central PMCID: PMC4096513.
- 29. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–8. Epub 2002/02/16. pmid:11846609.
- 30. Cui XS, Sun SC, Kang YK, Kim NH. Involvement of microRNA-335-5p in cytoskeleton dynamics in mouse oocytes. Reproduction, fertility, and development. 2013;25(4):691–9. pmid:22950940.
- 31. Perez GI, Acton BM, Jurisicova A, Perkins GA, White A, Brown J, et al. Genetic variance modifies apoptosis susceptibility in mature oocytes via alterations in DNA repair capacity and mitochondrial ultrastructure. Cell death and differentiation. 2007;14(3):524–33. Epub 2006/10/14. pmid:17039249.
- 32. Yang CR, Miao DQ, Zhang QH, Guo L, Tong JS, Wei Y, et al. Short-term preservation of porcine oocytes in ambient temperature: novel approaches. PloS one. 2010;5(12):e14242. Epub 2010/12/15. pmid:21151922; PubMed Central PMCID: PMC2998415.
- 33. Winterbourn CC. Toxicity of iron and hydrogen peroxide: the Fenton reaction. Toxicology letters. 1995;82–83:969–74. Epub 1995/12/01. pmid:8597169.
- 34. Barcroft LC, Offenberg H, Thomsen P, Watson AJ. Aquaporin proteins in murine trophectoderm mediate transepithelial water movements during cavitation. Developmental biology. 2003;256(2):342–54. Epub 2003/04/08. pmid:12679107.
- 35. Watson AJ, Pape C, Emanuel JR, Levenson R, Kidder GM. Expression of Na,K-ATPase alpha and beta subunit genes during preimplantation development of the mouse. Developmental genetics. 1990;11(1):41–8. Epub 1990/01/01. pmid:2163294.
- 36. Baltz JM, Tartia AP. Cell volume regulation in oocytes and early embryos: connecting physiology to successful culture media. Human reproduction update. 2010;16(2):166–76. Epub 2009/10/15. pmid:19825850.
- 37. Van Blerkom J, Davis P. Mitochondrial signaling and fertilization. Molecular human reproduction. 2007;13(11):759–70. Epub 2007/09/26. pmid:17893093.
- 38. Lee SK, Zhao MH, Kwon JW, Li YH, Lin ZL, Jin YX, et al. The association of mitochondrial potential and copy number with pig oocyte maturation and developmental potential. The Journal of reproduction and development. 2014;60(2):128–35. Epub 2014/02/05. pmid:24492657; PubMed Central PMCID: PMC3999391.
- 39. Lee SK, Zhao MH, Zheng Z, Kwon JW, Liang S, Kim SH, et al. Polymerase subunit gamma 2 affects porcine oocyte maturation and subsequent embryonic development. Theriogenology. 2015;83(1):121–30. Epub 2014/10/14. pmid:25308052.
- 40. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281(5381):1309–12. Epub 1998/08/28. pmid:9721092.
- 41. Desagher S, Martinou JC. Mitochondria as the central control point of apoptosis. Trends in cell biology. 2000;10(9):369–77. Epub 2000/08/10. pmid:10932094.
- 42. Leist M, Nicotera P. The shape of cell death. Biochemical and biophysical research communications. 1997;236(1):1–9. Epub 1997/07/09. pmid:9223415.
- 43. Vayssiere JL, Petit PX, Risler Y, Mignotte B. Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in cell lines conditionally immortalized with simian virus 40. Proceedings of the National Academy of Sciences of the United States of America. 1994;91(24):11752–6. Epub 1994/11/22. pmid:7972136; PubMed Central PMCID: PMC45310.
- 44. Jiang X, Wang X. Cytochrome C-mediated apoptosis. Annual review of biochemistry. 2004;73:87–106. Epub 2004/06/11. pmid:15189137.
- 45. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 2001;292(5517):727–30. Epub 2001/04/28. pmid:11326099; PubMed Central PMCID: PMC3049805.